Status:
COMPLETED
PRGF Effectiveness for Myofascial Pain Treatment in Masticatory Muscles
Lead Sponsor:
Lithuanian University of Health Sciences
Conditions:
Myofascial Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The investigators set up a randomized controlled clinical trial to evaluate the effectiveness of plasma rich in growth factors (PRGF) injections into the masseter muscle trigger points for myofascial ...
Eligibility Criteria
Inclusion
- Adult patients.
- Diagnosed myofascial pain syndrome in one side of the masseter muscle (diagnosis is based on diagnostic criteria described by Travell and Simons: 1) palpable taut band, 2) spot tenderness in a taut band, 3) pain recognition.
- Patients have never had injections into their masseter muscle.
Exclusion
- Myofascial trigger points in other masticatory muscles.
- Head and neck region inflammations that causes pain.
- Temporomandibular joint pathology which causes pain.
- Trigeminal nerve neuralgia.
- Head and neck region oncological diseases.
- Myofascial trigger points in both sides of masseter muscles.
Key Trial Info
Start Date :
May 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 25 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04040309
Start Date
May 10 2019
End Date
August 25 2019
Last Update
February 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LUHS Kaunas clinics Department of Maxillofacial surgery
Kaunas, Lithuania, LT-50161